Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV)

Latest Posts

RSV hospitalization in adults tied to risk of death and kidney, heart problems​
ACIP draft agenda revives anti-vaccine boilerplate topics​
Moderna receives expanded approval for RSV vaccine​
FDA approves Merck RSV monoclonal antibody shot for infants​
Flu, RSV linked to higher odds of secondary bacterial infection​
Study details economic impact of RSV infections in young children​
Studies estimate 75% RSV vaccine efficacy in older adults, profile risk for poor outcomes​
Hospital admissions of respiratory infections in infants plunge with nirsevimab RSV antibody​
RSV studies identify risk factors in older adults, household transmission routes​
Study shows nirsevimab provides significant protection against RSV​
RSV options: Most pregnant women, parents prefer the maternal RSV vaccine over the infant antibody shot​
Study details full range of what respiratory virus infections look like in young kids​
Asthma, chronic kidney disease and other high-risk conditions increase the risk for severe RSV illness​
Point-of-care respiratory virus testing in nursing homes could prevent hospital transfers​
Getting the RSV vaccine during pregnancy is a game-changer for infant hospitalizations​
CIDRAP Op-Ed: RSV—the middle child of respiratory season who deserves more attention​
Nirsevimab monoclonal antibody for RSV well tolerated in infants, study suggests​
Only 6 symptoms, conditions appear unique to long COVID, suggesting overlap with other post-viral infections​
RSV tied to high complication, death rates in hospitalized older adults​
Quick takes: Re-emergent COVID strain, extended US RSV season, typhus in California​